HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: R400004-MCP200v1 3/4/298    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hanash, S. Search for Related Content PubMed PubMed Citation Articles by Hanash, S. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 3:298-301, 2004.
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Review

HUPO Initiatives Relevant to Clinical Proteomics^*

Sam Hanash

From the Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI 48109

The past few years have seen a tremendous interest in the potential of proteomics to address unmet needs in biomedicine. Such unmet needs include more effective strategies for early disease detection and monitoring and more effective therapies, in addition to developing a better understanding of disease pathogenesis. Proteomics is particularly suited for investigating biological fluids to identify disease-related alterations and to develop molecular signatures for disease processes. However, much of the effort undertaken in clinical proteomics to date represents either demonstrations of principles or relatively small-scale studies when compared with genomics effort and accomplishments or more pertinently when contrasted with the tremendous untapped potential of clinical proteomics. Clearly, we are in the early stages. What seems to be urgently needed is an organized effort to build a solid foundation for proteomics that includes developing a much needed infrastructure with adequate resources. The Human Proteome Organization (HUPO) is fostering an organized international effort in proteomics that includes initiatives around organ systems and biological fluids that have disease relevance as well as development of proteomics resources.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. J. Grant and C. C. Wu Advances in neuromembrane proteomics: efforts towards a comprehensive analysis of membrane proteins in the brain Briefings in Functional Genomics, March 12, 2007; (2007) elm001v1. [Abstract] [Full Text] [PDF]

				R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]

				M. Uhlen, E. Bjorling, C. Agaton, C. A.-K. Szigyarto, B. Amini, E. Andersen, A.-C. Andersson, P. Angelidou, A. Asplund, C. Asplund, et al. A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics Mol. Cell. Proteomics, December 1, 2005; 4(12): 1920 - 1932. [Abstract] [Full Text] [PDF]

				M. Uhlen and F. Ponten Antibody-based Proteomics for Human Tissue Profiling Mol. Cell. Proteomics, April 1, 2005; 4(4): 384 - 393. [Abstract] [Full Text] [PDF]